This report describes the first clinical experience with the new Occlutech Atrial Flow Regulator (AFR®) device for implementation of a late Fontan fenestration. The AFR® device secured a defined diameter of the fenestration without spontaneous re-occlusion of this extra-anatomic perforation. This ensured a permanent clinical improvement of our failing Fontan patient.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S1047951118000720 | DOI Listing |
Publication Analysis
Top Keywords
fontan fenestration
8
occlutech atrial
8
atrial flow
8
flow regulator
8
regulator afr®
8
afr® device
8
creation defined
4
defined stable
4
stable fontan
4
fenestration occlutech
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!